Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease.
about
Network-based analysis of comorbidities risk during an infection: SARS and HIV case studiesNew Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney DiseaseTranscriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney DiseaseThe molecular mechanisms of hemodialysis vascular access failureMitochondria: a new therapeutic target in chronic kidney diseaseAOPPs and the progression of kidney diseaseEffect of redox modulating NRF2 activators on chronic kidney diseaseOxidative stress and nucleic acid oxidation in patients with chronic kidney diseaseDownregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patientsImproved mitochondrial function underlies the protective effect of pirfenidone against tubulointerstitial fibrosis in 5/6 nephrectomized ratsThe serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease.Mitochondria in monocytes and macrophages-implications for translational and basic researchIntegrative biology identifies shared transcriptional networks in CKD.Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases.A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patientsA 3-biomarker-panel predicts renal outcome in patients with proteinuric renal diseases.NLRP3 inflammasome activation in dialyzed chronic kidney disease patients.Antioxidant vitamins status in children and young adults undergoing dialysis: A single center studyMitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction.Caveolin-1 Expression Ameliorates Nephrotic Damage in a Rabbit Model of Cholesterol-Induced Hypercholesterolemia.Comparative study of extrapolative factors linked with oxidative injury and anti-inflammatory status in chronic kidney disease patients experiencing cardiovascular distressImpaired vitamin D metabolism in CKDThe Biology of Hemodialysis Vascular Access FailureMitochondrial dysfunction and oxidative stress in patients with chronic kidney disease.Increased abundance of ADAM9 transcripts in the blood is associated with tissue damage.Co-Expression Analysis of Blood Cell Genome Expression to Preliminary Investigation of Regulatory Mechanisms in Uremia.Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cellsPharmacogenomics: a new paradigm to personalize treatments in nephrology patients.NLRP3 Deficiency Attenuates Renal Fibrosis and Ameliorates Mitochondrial Dysfunction in a Mouse Unilateral Ureteral Obstruction Model of Chronic Kidney Disease.What we know about oxidative stress in patients with chronic kidney disease on dialysis--clinical effects, potential treatment, and prevention.Mitochondrial dysfunction in the pathophysiology of renal diseases.Fetal programming of chronic kidney disease: the role of maternal smoking, mitochondrial dysfunction, and epigenetic modfification.Uremia induces adipose tissue inflammation and muscle mitochondrial dysfunction.Effect of Chronic Kidney Disease and Supplemental Polyunsaturated Fatty Acid Use on Exercise Levels During Cardiac Rehabilitation in Patients With Coronary Artery Disease.Oxidative stress-induced alterations in PPAR-γ and associated mitochondrial destabilization contribute to kidney cell apoptosis.Dialysis-related transcriptomic profiling: the pivotal role of heparanase.Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease.Association between Mitochondrial DNA Copy Number in Peripheral Blood and Incident CKD in the Atherosclerosis Risk in Communities Study.Pioglitazone Improves Mitochondrial Function in the Remnant Kidney and Protects against Renal Fibrosis in 5/6 Nephrectomized Rats.Antioxidants and Cardiovascular Risk Factors.
P2860
Q21284301-6AAF86C5-B72C-4A1D-8A73-F959D433584CQ26739475-8FBB2036-C928-42B7-B598-55BE52D61FEAQ26740125-0E901587-9B2F-46D2-BDAF-07CDEC6716A3Q26775058-7452719C-C2A0-429B-8757-614FF4C47274Q26776397-1BEA0ED1-B077-4D11-A149-D91A97962FA2Q26796619-35AF8494-99CC-452A-BEB7-1DE6DAD8335AQ26827726-843108D5-906B-42F7-A95F-D5BF86AF7086Q27006908-9AA8496E-AE62-494F-83BB-FC6BC32EC948Q28534658-D425BDF3-4871-44EA-A6FB-C72FC774C050Q28536610-AAA6BD00-8989-4D6D-B503-DD7A15F00077Q30524695-79B57721-DE66-4888-89F3-8EDA360824AAQ33954232-831AB7E4-055B-45C0-B749-61D1A3516F17Q34427636-AB36221B-C7FA-4497-AE8B-C696C0442F39Q34538482-1CE3C453-F8BE-487D-923C-4159CD51DDFDQ34714685-1500ABFD-D4F4-4A7D-AD25-6C3FDC5BE34AQ34995501-4039E95C-6A5A-4EAA-B9C4-9E74DEC39AEFQ35208558-427EB425-4499-4B5E-AA6A-C8829921E0D2Q35830272-E47B1DDF-B38F-42AC-BCEC-854E27AE078EQ35846798-A2BF9651-AA3F-4199-9953-CADAC73FCCC4Q36001843-9CCEFC31-C038-4503-A35E-4F9BC272AC42Q36274244-E0BF9A41-5A5B-46DB-997B-78751F7AD5BCQ36668070-49A43D52-A71F-4A24-BC97-C70AACE4AF5CQ36716833-9838B29D-D36F-4B6B-A1A3-9B483EA04E7FQ36918729-C83C486A-8BFD-49DB-80D1-F5E8622B7595Q37458109-EBE1BE35-16E1-4C80-88CC-226023DAB413Q37582744-697E5738-A52D-4998-8556-2FD5513F09A8Q37625953-14CD11A7-1CCC-4410-BA02-583D47D6779CQ37646842-CB5865A8-5244-4631-8BCA-320E0384EB7BQ37699992-CC7315B3-18BC-45AA-A938-184BF53D1A9DQ37837005-C229AB84-2829-469E-83EF-CC61F24A28C2Q38168664-06930540-AC0F-4AB1-B371-E4CAE7C6A0A5Q38345872-6B24A397-0648-41DA-9936-C41D8D60EE97Q38729665-96842F6E-BBC3-45E9-8CE8-C0F488970BE1Q38920050-08D58727-4135-4919-B7B3-FCA70BE5EC46Q38966233-FAED2D9C-A1A3-4AC3-A2C8-D6AFF43DCB8AQ39321185-5E335E62-BDD3-4EBB-8341-AB5F1AE6F5ACQ39429579-96CFA1F3-16FB-41D0-8141-AA6F11D1787EQ40960238-28D10B4B-4BB5-44A5-89A5-644AAFC1CEBCQ41437002-038D55AF-2670-4EDF-91EB-1ED03DA7B3E9Q42226794-48581837-1A05-4946-AB31-8DC0FAE33005
P2860
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease.
@ast
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease.
@en
type
label
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease.
@ast
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease.
@en
prefLabel
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease.
@ast
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease.
@en
P2093
P2860
P50
P356
P1433
P1476
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease.
@en
P2093
Dominga Latorre
Francesco Paolo Schena
Gaetano Villani
Giuseppe Grandaliano
Simona Simone
P2860
P2888
P356
10.1186/1471-2164-10-388
P407
P577
2009-08-21T00:00:00Z
P5875
P6179
1019727498